Clinical Trial Update: A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Women With Endometriosis From Study M01-398 [Phase 2]

View source ↗

Summary

This update reports the long-term safety results of Asoprisnil in women with endometriosis from the Phase 2 study M01-398. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Asoprisnil (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Endometriosis | Phase 2 | Status: COMPLETED